Sanofi preps API spin­off for Paris ex­change list­ing, share­hold­ers reap div­i­dend

Two years af­ter the com­pa­ny spun out its phar­ma­ceu­ti­cal in­gre­di­ent op­er­a­tions, Sanofi is list­ing the API com­pa­ny on the Paris stock ex­change.

Sanofi ex­pects to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER